Lazard Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67K | Sell |
2,055
-34,113
| -94% | -$1.11M | ﹤0.01% | 1956 |
|
|
2025
Q1 | $1.45M | Buy |
+36,168
| New | +$1.45M | ﹤0.01% | 1069 |
|
|
2023
Q3 | – | Sell |
-24,716
| Closed | -$806K | – | 2314 |
|
|
2023
Q2 | $806K | Sell |
24,716
-10,292
| -29% | -$336K | ﹤0.01% | 1028 |
|
|
2023
Q1 | $1.23M | Sell |
35,008
-4,120
| -11% | -$145K | ﹤0.01% | 987 |
|
|
2022
Q4 | $1.79M | Sell |
39,128
-12,017
| -23% | -$550K | ﹤0.01% | 918 |
|
|
2022
Q3 | $2.48M | Sell |
51,145
-1,648,281
| -97% | -$79.8M | ﹤0.01% | 843 |
|
|
2022
Q2 | $66.8M | Buy |
1,699,426
+1,697,631
| +94,576% | +$66.7M | 0.09% | 196 |
|
|
2022
Q1 | $66K | Buy |
1,795
+1,695
| +1,695% | +$62.3K | ﹤0.01% | 1599 |
|
|
2021
Q4 | $4K | Hold |
100
| – | – | ﹤0.01% | 2178 |
|
|
2021
Q3 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 2107 |
|
|
2021
Q2 | – | Sell |
-114,478
| Closed | -$2.66M | – | 1981 |
|
|
2021
Q1 | $2.66M | Sell |
114,478
-28,921
| -20% | -$673K | ﹤0.01% | 754 |
|
|
2020
Q4 | $2.98M | Sell |
143,399
-118,115
| -45% | -$2.45M | ﹤0.01% | 726 |
|
|
2020
Q3 | $5.66M | Sell |
261,514
-8,076
| -3% | -$175K | 0.01% | 587 |
|
|
2020
Q2 | $6.35M | Buy |
+269,590
| New | +$6.35M | 0.01% | 533 |
|